SEC Form 4 · accession 0001731122-18-000017
Enochian Biosciences Inc · ENOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
May 16, 2018
Accepted (ET)
Jun 4, 2018 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001527728
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2018 | P | 190 | $5.50 | A | 71,492 | D | |
| Common Stock | May 17, 2018 | P | 754 | $5.40 | A | 72,246 | D | |
| Common Stock | May 22, 2018 | P | 300 | $5.25 | A | 72,546 | D | |
| Common Stock | May 24, 2018 | P | 200 | $5.33 | A | 72,746 | D | |
| Common Stock | May 24, 2018 | P | 500 | $5.25 | A | 73,246 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Explanation of Responses (1) From May 16, 2018 - May 24, 2018, Dr. Leire purchased an aggregate of 1,944 shares of common stock of Issuer.